These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37690230)

  • 1. Involvement of cell surface glycosaminoglycans in chebulagic acid's and punicalagin's antiviral activities against Coxsackievirus A16 infection.
    Liu CH; Kuo YT; Lin CJ; Lin LT
    Phytomedicine; 2023 Nov; 120():155047. PubMed ID: 37690230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.
    Lin CJ; Liu CH; Wang JY; Lin CC; Li YF; Richardson CD; Lin LT
    Emerg Microbes Infect; 2018 Sep; 7(1):162. PubMed ID: 30254193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.
    Lin LT; Chen TY; Lin SC; Chung CY; Lin TC; Wang GH; Anderson R; Lin CC; Richardson CD
    BMC Microbiol; 2013 Aug; 13():187. PubMed ID: 23924316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.
    Lin LT; Chen TY; Chung CY; Noyce RS; Grindley TB; McCormick C; Lin TC; Wang GH; Lin CC; Richardson CD
    J Virol; 2011 May; 85(9):4386-98. PubMed ID: 21307190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor.
    Zhang X; Shi J; Ye X; Ku Z; Zhang C; Liu Q; Huang Z
    Emerg Microbes Infect; 2017 Jul; 6(7):e65. PubMed ID: 28745308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
    Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
    J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
    McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of antibody neutralization of coxsackievirus A16.
    Zhang C; Liu C; Shi J; Wang Y; Xu C; Ye X; Liu Q; Li X; Qiao W; Yin Y; Cong Y; Huang Z
    Nat Commun; 2022 Dec; 13(1):7854. PubMed ID: 36543790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL
    Du R; Cooper L; Chen Z; Lee H; Rong L; Cui Q
    Antiviral Res; 2021 Jun; 190():105075. PubMed ID: 33872675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional motions and related key residues behind the uncoating of coxsackievirus A16.
    He XL; Du LF; Zhang J; Liang Y; Wu YD; Su JG; Li QM
    Proteins; 2021 Oct; 89(10):1365-1375. PubMed ID: 34085313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16.
    Wang JY; Lin CJ; Liu CH; Lin LT
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31355786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
    O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
    J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate.
    Pourianfar HR; Kirk K; Grollo L
    Virusdisease; 2014; 25(3):277-84. PubMed ID: 25674594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Mechanisms of Saucerneol from
    Song JH; Mun SH; Yang H; Kwon YS; Kim SR; Song MY; Ham Y; Choi HJ; Baek WJ; Cho S; Ko HJ
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.